Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998-2008
- PMID: 22003308
- PMCID: PMC3191114
- DOI: 10.2147/CLEP.S17189
Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998-2008
Abstract
Objective: Infants with chronic lung disease of infancy (CLDI) are at high risk for severe respiratory syncytial virus (RSV) illness requiring hospitalization. Palivizumab was first licensed in 1998 for the prevention of RSV disease in high-risk infants, including those with CLDI. We performed a retrospective cohort study of all hospitalized children with CLDI aged <2 years between 1998 and 2008 in the USA to determine trends in rates of hospitalizations due to RSV (RSVH) since the launch of palivizumab.
Materials and methods: Data from the United States National Hospital Discharge Survey, a multistage systematic survey sample of US hospitals, were assembled. We defined RSVH using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes of 079.6 (RSV), 466.11 (acute bronchiolitis due to RSV), and 480.1 (pneumonia due to RSV). Quarterly rates of RSVH were assessed for children with CLDI (ICD-9-CM code 770.7) and calculated between 1998 and 2008. Because RSV may be miscoded, the analysis was repeated after expanding the definition of RSVH to include all acute bronchitis and acute bronchiolitis (ABH) (ICD-9-CM = 466). Trends were described using linear regression with seasonal indicators included in the model.
Results: On average, about 966 RSVH (range 98-1373 RSVH) per year were found for children <2 years with CLDI in the USA between 1998 and 2008. Over the 11-year period, the predicted rate of RSVH statistically significantly decreased by 48% (from 93.78 to 49.06 RSVH per 1 million children) (P = 0.013). Addition of ABH resulted in a nonstatisically significant decrease of 32% over the 10-year period (P = 0.102).
Conclusion: These results suggest that there has been a decrease in the rate of RSVH in infants with CLDI between 1998 and 2008. The reasons for this decrease may include improved neonatal intensive care unit and outpatient management of CLDI, and possibly increased use of palivizumab in this high-risk population.
Keywords: CLDI; RSV; bronchiolitis; palivizumab.
Figures
Similar articles
-
Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study.Adv Ther. 2011 Mar;28(3):195-201. doi: 10.1007/s12325-010-0106-6. Epub 2011 Feb 7. Adv Ther. 2011. PMID: 21327753
-
A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year.J Infect Dis. 2022 Aug 15;226(Suppl 2):S195-S212. doi: 10.1093/infdis/jiac201. J Infect Dis. 2022. PMID: 35968876 Free PMC article.
-
RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020.Hum Vaccin Immunother. 2022 Nov 30;18(6):2140533. doi: 10.1080/21645515.2022.2140533. Epub 2022 Nov 22. Hum Vaccin Immunother. 2022. PMID: 36412253 Free PMC article.
-
Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus.Hum Vaccin Immunother. 2014;10(3):607-14. doi: 10.4161/hv.27426. Epub 2013 Dec 6. Hum Vaccin Immunother. 2014. PMID: 24316863 Free PMC article. Review.
-
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46. J Manag Care Pharm. 2010. PMID: 20131495 Free PMC article. Review.
Cited by
-
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?Front Immunol. 2022 Apr 28;13:880368. doi: 10.3389/fimmu.2022.880368. eCollection 2022. Front Immunol. 2022. PMID: 35572550 Free PMC article. Review.
-
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease.Infect Dis Ther. 2016 Dec;5(4):453-471. doi: 10.1007/s40121-016-0137-7. Epub 2016 Nov 18. Infect Dis Ther. 2016. PMID: 27864751 Free PMC article. Review.
-
Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012.PLoS One. 2016 Apr 6;11(4):e0152208. doi: 10.1371/journal.pone.0152208. eCollection 2016. PLoS One. 2016. PMID: 27050095 Free PMC article.
-
Social, economic, and health impact of the respiratory syncytial virus: a systematic search.BMC Infect Dis. 2014 Oct 30;14:544. doi: 10.1186/s12879-014-0544-x. BMC Infect Dis. 2014. PMID: 25358423 Free PMC article. Review.
-
Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a national surveillance system.Pediatr Infect Dis J. 2014 Jun;33(6):589-94. doi: 10.1097/INF.0000000000000257. Pediatr Infect Dis J. 2014. PMID: 24445835 Free PMC article.
References
-
- Allen J, Zwerdling R, Ehrenkranz R, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med. 2003;168(3):356–396. - PubMed
-
- Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19):1946–1955. - PubMed
-
- Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988;82(2):199–203. - PubMed
-
- Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. Pediatrics. 1998;102(5):1211–1216. - PubMed
-
- United States Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), Bridged-Race Population Estimates, United States July 1st resident population by state, county, age, sex, bridged-race, and Hispanic origin, compiled from 1990–1999 bridged-race intercensal population estimates and 2000–2009 (Vintage 2009) bridged-race postcensal population estimates, on CDC WONDER On-line Database. Available from: http://wonder.cdc.gov/bridged-race-v2009.html. Accessed April 1, 2011.
LinkOut - more resources
Full Text Sources